Dissecting Paclitaxel-microtubule Association: Quantitative Assessment of the 2'-OH Group

Overview

Journal Biochemistry

Specialty Biochemistry

Date 2013 Mar 12

PMID 23473345

Citations 18

Authors

Shubhada Sharma

Chandraiah Lagisetti

Barbara Poliks

Robert M Coates

David G I Kingston

Susan Bane

Affiliations

Soon will be listed here.

Abstract

Paclitaxel (PTX) is a microtubule-stabilizing agent that is widely used in cancer chemotherapy. This structurally complex natural product acts by binding to β-tubulin in assembled microtubules. The 2'-hydroxyl group in the flexible side chain of PTX is an absolute requirement for activity, but its precise role in the drug-receptor interaction has not been specifically investigated. The contribution of the 2'-OH group to the affinity and tubulin-assembly efficacy of PTX has been evaluated through quantitative analysis of PTX derivatives possessing side chain deletions: 2'-deoxy-PTX, N-debenzoyl-2'-deoxy-PTX, and baccatin III. The affinity of 2'-deoxy-PTX for stabilized microtubules was more than 100-fold lower than that of PTX and only ~3-fold greater than the microtubule affinity of baccatin III. No microtubule binding activity was detected for the analogue N-debenzoyl-2'-deoxy-PTX. The tubulin-assembly efficacy of each ligand was consistent with the microtubule binding affinity, as was the trend in cytotoxicities. Molecular dynamics simulations revealed that the 2'-OH group of PTX can form a persistent hydrogen bond with D26 within the microtubule binding site. The absence of this interaction between 2'-deoxy-PTX and the receptor can account for the difference in binding free energy. Computational analyses also provide a possible explanation for why N-debenzoyl-2'-deoxy-PTX is inactive, in spite of the fact that it is essentially a substituted baccatin III. We propose that the hydrogen bonding interaction between the 2'-OH group and D26 is the most important stabilizing interaction that PTX forms with tubulin in the region of the C-13 side chain. We further hypothesize that the substituents at the 3'-position function to orient the 2'-OH group for a productive hydrogen bonding interaction with the protein.

Citing Articles

Activation of the PERK/eIF2α axis is a pivotal prerequisite of taxanes to cancer cell apoptosis and renders synergism to overcome paclitaxel resistance in breast cancer cells.

Cai W, Rong D, Ding J, Zhang X, Wang Y, Fang Y Cancer Cell Int. 2024; 24(1):249.

PMID: 39020371 PMC: 11256575. DOI: 10.1186/s12935-024-03443-w.

Synthesis of Monofluorinated 7-Hydroxycoumarin-3-Carboxamides as Cell-Permeable Fluorescent Molecular Probes.

Rane D, Shaik A, Lee S, Hu X, Peterson B ACS Med Chem Lett. 2024; 15(5):677-683.

PMID: 38746887 PMC: 11089655. DOI: 10.1021/acsmedchemlett.4c00085.

Visible light-activated prodrug system with a novel heavy-atom-free photosensitizer.

Yang S, Wang L, Loredo A, Wang S, Ada N, Xiao H Bioorg Med Chem Lett. 2023; 91:129365.

PMID: 37290494 PMC: 11298069. DOI: 10.1016/j.bmcl.2023.129365.

Quantification of Engagement of Microtubules by Small Molecules in Living Cells by Flow Cytometry.

Andres A, Mariano A, Rane D, Peterson B ACS Bio Med Chem Au. 2022; 2(5):529-537.

PMID: 36281300 PMC: 9585582. DOI: 10.1021/acsbiomedchemau.2c00031.

Drugs That Changed Society: Microtubule-Targeting Agents Belonging to Taxanoids, Macrolides and Non-Ribosomal Peptides.

Christensen S Molecules. 2022; 27(17).

PMID: 36080414 PMC: 9457747. DOI: 10.3390/molecules27175648.

References

Entwistle R, Winefield R, Foland T, Lushington G, Himes R . The paclitaxel site in tubulin probed by site-directed mutagenesis of Saccharomyces cerevisiae beta-tubulin. FEBS Lett. 2008; 582(16):2467-70. PMC: 2577837. DOI: 10.1016/j.febslet.2008.06.013. View

Li Y, Edsall Jr R, Jagtap P, Kingston D, Bane S . Equilibrium studies of a fluorescent paclitaxel derivative binding to microtubules. Biochemistry. 2000; 39(3):616-23. DOI: 10.1021/bi992044u. View

Timasheff S, Grisham L . In vitro assembly of cytoplasmic microtubules. Annu Rev Biochem. 1980; 49:565-91. DOI: 10.1146/annurev.bi.49.070180.003025. View

Yang Y, Alcaraz A, Snyder J . The tubulin-bound conformation of paclitaxel: T-taxol vs "PTX-NY". J Nat Prod. 2009; 72(3):422-9. DOI: 10.1021/np800662j. View

Fu Y, Li S, Zu Y, Yang G, Yang Z, Luo M . Medicinal chemistry of paclitaxel and its analogues. Curr Med Chem. 2009; 16(30):3966-85. DOI: 10.2174/092986709789352277. View

Gupta Jr M, Bode C, Georg G, Himes R . Understanding tubulin-Taxol interactions: mutations that impart Taxol binding to yeast tubulin. Proc Natl Acad Sci U S A. 2003; 100(11):6394-7. PMC: 164457. DOI: 10.1073/pnas.1131967100. View

Han Y, Chaudhary A, Chordia M, Sackett D, Kingston D, Bane S . Interaction of a fluorescent derivative of paclitaxel (Taxol) with microtubules and tubulin-colchicine. Biochemistry. 1996; 35(45):14173-83. DOI: 10.1021/bi960774l. View

Snyder J, Nettles J, Cornett B, Downing K, Nogales E . The binding conformation of Taxol in beta-tubulin: a model based on electron crystallographic density. Proc Natl Acad Sci U S A. 2001; 98(9):5312-6. PMC: 33206. DOI: 10.1073/pnas.051309398. View

Canales A, Rodriguez-Salarichs J, Trigili C, Nieto L, Coderch C, Andreu J . Insights into the interaction of discodermolide and docetaxel with tubulin. Mapping the binding sites of microtubule-stabilizing agents by using an integrated NMR and computational approach. ACS Chem Biol. 2011; 6(8):789-99. DOI: 10.1021/cb200099u. View

10.

Andreu J, Barasoain I . The interaction of baccatin III with the taxol binding site of microtubules determined by a homogeneous assay with fluorescent taxoid. Biochemistry. 2001; 40(40):11975-84. DOI: 10.1021/bi010869+. View

11.

Diaz J, Strobe R, Engelborghs Y, Souto A, Andreu J . Molecular recognition of taxol by microtubules. Kinetics and thermodynamics of binding of fluorescent taxol derivatives to an exposed site. J Biol Chem. 2000; 275(34):26265-76. DOI: 10.1074/jbc.M003120200. View

12.

Manfredi J, Horwitz S . Taxol: an antimitotic agent with a new mechanism of action. Pharmacol Ther. 1984; 25(1):83-125. DOI: 10.1016/0163-7258(84)90025-1. View

13.

Buey R, Barasoain I, Jackson E, Meyer A, Giannakakou P, Paterson I . Microtubule interactions with chemically diverse stabilizing agents: thermodynamics of binding to the paclitaxel site predicts cytotoxicity. Chem Biol. 2005; 12(12):1269-79. DOI: 10.1016/j.chembiol.2005.09.010. View

14.

Jimenez-Barbero J, Souto A, Abal M, Barasoain I, Evangelio J, Acuna A . Effect of 2'-OH acetylation on the bioactivity and conformation of 7-O-[N-(4'-fluoresceincarbonyl)-L-alanyl]taxol. A NMR-fluorescence microscopy study. Bioorg Med Chem. 1998; 6(10):1857-63. DOI: 10.1016/s0968-0896(98)00149-7. View

15.

Sun L, Simmerling C, Ojima I . Recent advances in the study of the bioactive conformation of taxol. ChemMedChem. 2009; 4(5):719-31. PMC: 3072276. DOI: 10.1002/cmdc.200900044. View

16.

Nogales E, Wolf S, Downing K . Structure of the alpha beta tubulin dimer by electron crystallography. Nature. 1998; 391(6663):199-203. DOI: 10.1038/34465. View

17.

Guenard D, Lavelle F, Le Goff M, Mangatal L, Potier P . Relationships between the structure of taxol analogues and their antimitotic activity. J Med Chem. 1991; 34(3):992-8. DOI: 10.1021/jm00107a017. View

18.

Mellado W, Magri N, Kingston D, Orr G, Horwitz S . Preparation and biological activity of taxol acetates. Biochem Biophys Res Commun. 1984; 124(2):329-36. DOI: 10.1016/0006-291x(84)91557-2. View

19.

Sharma S, Ganesh T, Kingston D, Bane S . Promotion of tubulin assembly by poorly soluble taxol analogs. Anal Biochem. 2006; 360(1):56-62. PMC: 1868410. DOI: 10.1016/j.ab.2006.10.014. View

20.

Williams Jr R, Lee J . Preparation of tubulin from brain. Methods Enzymol. 1982; 85 Pt B:376-85. DOI: 10.1016/0076-6879(82)85038-6. View